MAScIR (Moroccan Foundation for Advanced Science Innovation & Research) and UK company Mologic Ltd, a world leader in the design of point of need diagnostic testing, have signed a partnership agreement in the field of medical biology and the development of molecular diagnostic kits for infectious diseases.
The signing of the partnership protocol took place at the headquarters of the foundation in Rabat, in the presence of Thomas Reilly, Ambassador of the United Kingdom to Morocco.
MAScIR and Mologic have agreed to collaborate and share expertise in developing novel diagnostic tests for epidemics, as well as biosimilars, MAScIR said in a press release.
MAScIR is a Moroccan non-profit foundation which aims to promote and develop R&D centers in advanced technologies, hence meeting the specific medical biology needs of Morocco.
Through its expert team and cutting edge technology, MAScIR has demonstrated its track record and credentials in scientific and applied research through patents, scientific articles and successful projects with national and foreign manufacturers. More recently, MAScIR has developed an RT-PCR test for the new coronavirus in just a few weeks.
Mologic is one of the world leaders in rapid diagnostic technologies and through global partnerships is developing the next-generation of ultra-sensitive point-of-need diagnostics which are easy to use and low cost to manufacture – critical to the success of many global health programmes.
Mologic’s co-founder and Scientific Director, Paul DAVIS, was co- inventor of the Clearblue pregnancy test, launched in 1988. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since its formation in 2003 and has led to many key innovations in the field of rapid diagnosis.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.